Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00026
Species: Homo sapiens
Position : chr6:101482232-101483107
Year: 2025
Title: Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  40729681
MONDO: MONDO:0004945
Tissue: Bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: Primary human KMT2A::AFF1 ALL blasts
CVCL ID:
Cell Type: Primary leukemic blast cell
Cell Ontology ID: CL:0000692
Experiment Type: Micro-Capture-C chromatin interaction + patient gene expression validation, ChIP-qPCR
High Throughput Method: scMultiome ATAC+RNA-seq, TOPmentation H3K27ac profiling, Micro-Capture-C, WGS
Low Throughput Method: RT-qPCR, FACS cell sorting, patient primary cell culture
About Target Gene
Target gene : MEIS1
About TF
TF name : AFF1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_00025 chr6:101482232-101483107 Bone marrow Primary leukemic blast cell B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer